These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1810184)

  • 21. Effect of famotidine on ciprofloxacin pharmacokinetics after single intravenous and oral doses in rats.
    al-Khamis KI; Jim LK; Bawazir SA; Ashour LF; el-Sayed N; el-Sayed YM
    J Clin Pharm Ther; 1994 Dec; 19(6):335-9. PubMed ID: 7876363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration.
    McKellar Q; Gibson I; Monteiro A; Bregante M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1988-92. PubMed ID: 10428924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
    Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
    Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.
    Dan M; Torossian K; Weissberg D; Kitzes R
    Eur J Clin Pharmacol; 1993; 44(1):101-2. PubMed ID: 8436147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
    Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ciprofloxacin in ponies.
    Dowling PM; Wilson RC; Tyler JW; Duran SH
    J Vet Pharmacol Ther; 1995 Feb; 18(1):7-12. PubMed ID: 7752310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.
    Heim-Duthoy K; Peltier G; Awni W
    Antimicrob Agents Chemother; 1990 May; 34(5):922-3. PubMed ID: 2113797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleural penetration of ciprofloxacin in patients with empyema thoracis.
    Morgenroth A; Pfeuffer HP; Seelmann R; Schweisfurth H
    Chest; 1991 Aug; 100(2):406-9. PubMed ID: 1864115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis.
    Geny F; Costa P; Bressolle F; Galtier M
    Biopharm Drug Dispos; 1993 Mar; 14(2):161-9. PubMed ID: 8453025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration of intravenous and oral ciprofloxacin into sterile and empyemic human pleural fluid.
    Joseph J; Vaughan LM; Basran GS
    Ann Pharmacother; 1994 Mar; 28(3):313-5. PubMed ID: 8193415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of ciprofloxacin in cystic fibrosis.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Heggen L; Stempel D; Smith AL
    Antimicrob Agents Chemother; 1987 Jun; 31(6):915-9. PubMed ID: 3619423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.
    Pryka RD; Rodvold KA; Ting W; Levitsky S; Frost RW; Lettieri JT
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2106-11. PubMed ID: 8257131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.